Evidence map›Paper›PMID 38831778›Full record

ArticleHealth science reports2024

Lingering challenges in malaria elimination efforts in sub-Saharan Africa: Insights and potential solutions.

Lukman Lawal, Ahmad Oyindamola Buhari, Tawakalitu Abdulateef Jaji, Abdulrahman Salaudeen Alatare, Abdulmalik Opeyemi Adeyemo, Aishat Oluwakemi Olumoh, Yusuff Adesoji Yusuff, Gabriel Osborn, Abdulazeez Biodun Mogaji, Bello Hussein Adoto and 3 more

Abstract read
In one paragraph

Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lukman LawalCentre for Malaria and Other Tropical Diseases Ilorin Nigeria.ORCID 0000-0003-3398-7449
Ahmad Oyindamola BuhariFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Tawakalitu Abdulateef JajiFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Abdulrahman Salaudeen AlatareFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Abdulmalik Opeyemi AdeyemoFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Aishat Oluwakemi OlumohFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Yusuff Adesoji YusuffFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Gabriel OsbornFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Abdulazeez Biodun MogajiFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Bello Hussein AdotoFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Nafisa Gbemisola IbrahimFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Waliyullahi Oluwafemi SaliuFaculty of Clinical Sciences University of Ilorin Ilorin Nigeria.
Toufik Abdul-RahmanMedical Institute Sumy State University Sumy Ukraine.ORCID 0000-0003-0153-287X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Between 2000 and 2015, significant gains were recorded in reducing the global burden of malaria due to enhanced global collaboration and increased funding. However, progress has stagnated post-2015, and the COVID-19 pandemic seems to have reversed some of these gains, necessitating a critical reevaluation of interventions. This paper aims to analyze the setbacks and offer recommendations for advancement in malaria control and prevention in sub-Saharan Africa. Methods: We conducted searches on Google Scholar, PubMed, and relevant organization websites to identify relevant studies on malaria control and prevention and associated challenges in sub-Saharan Africa from 2015 to the present. Additionally, studies on individual sub-Saharan African countries were reviewed to ensure comprehensiveness. Data from selected studies were extracted and analyzed using a narrative synthesis approach to offer a concise overview of the evidence. Findings: We observe that the halt in progress of malaria control in sub-Saharan Africa has deep roots in socioeconomic, political, and environmental factors. These challenges are exacerbated by the population explosion in the region, low coverage of interventions due to funding deficits and incessant crises, and the degradation of the efficacy of existing malaria commodities. Conclusion: Sub-Saharan Africa is at a crossroads in its fight against malaria. Promising new frontiers such as malaria vaccines, preventive monoclonal antibodies, new-generation insecticide-treated nets, and potentially artificial intelligence-driven technologies offer hope in advancing malaria control and prevention in the region. Through commitment and collaboration, leveraging these opportunities can help surmount challenges and ultimately eliminate malaria in sub-Saharan Africa.

Indexed as

artemisinin combination therapyinsecticide treated netmalaria control and eliminationPlasmodium sppR21/Matrix‐MTM malaria vaccineRTSSsub‐Saharan Africaworld malaria report

Identifiers

PMID38831778
PMCPMC11144596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.